Interpace Biosciences, Inc. (IDXG)

OTCMKTS · Delayed Price · Currency is USD

0.7800

-0.0200 (-2.50%)

Jul 9, 2025, 11:48 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Diagnostic Clinical Services	40.21M	Log In	Log In	Log In	Log In	Upgrade
Diagnostic Clinical Services Growth	26.31%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	40.21M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	26.31%	Log In	Log In	Log In	Log In	Upgrade